Eculizumab

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Eculizumab and local guidelines before prescribing.

Complement inhibitor

Mechanism

Complement C5 inhibitor.

Uses

Paroxysmal nocturnal haemoglobinuria, atypical haemolytic uraemic syndrome, myasthenia gravis (refractory), NMOSD.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Meningococcal infection, infusion reactions, headache.

Interactions

Few; other immunosuppressants add infection risk.

Contraindications and cautions

Unresolved Neisseria meningitidis infection, no meningococcal vaccination

Monitoring

Infection signs, haemolysis markers

Pregnancy and breastfeeding

Avoid unless essential

Renal and hepatic impairment

No adjustment

Overdose and reversal

Supportive

Special advice

Meningococcal vaccination at least 2 weeks before and antibiotic prophylaxis; patient alert card.

More from the textbook: uses, cautions and other points
Where it is discussed in the book